The Board granted the Veteran's claim for service connection for leukopenia, reopening it based on new evidence. The decision also addressed the methodology used by VA to measure radiation exposure.
The deciding factor: The Board found that the June 2014 dose estimate was based on sound scientific evidence and did not rely on the LA Report as referenced in the June 2014 revised dose estimate from the Air Force Medical Support Agency.
- Claimed conditions
- leukopenia
- How they argued it
- Not specified
- Exposure basis
- Ionizing radiation
- Rating
- Not verified here — check the original decision
- Decision date
- March 26, 2019
- Citation
- 19122404
Veterans Law Judge
Decisions by this judge: 1,987 · Granted: 15% (granted or partly granted, in the indexed decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 19122404.
What this means for you
A grant means the Board allowed the benefit or issue identified in this decision. Review the original order: other issues in the same appeal may have a different outcome, and this decision does not predict another claim.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Remanded (sent back)
The Veteran's claim for service connection for a blood/bone marrow disorder, including myelodysplastic syndrome, leukopenia, and neutropenia, is being remanded due to the submission of new and relevant evidence. The Board acknowledges that the Veteran was exposed to Agent Orange during his military service in Vietnam.
- Whole decision: Denied
The Veteran's leukopenia has not required continuous medication for control or intermittent use of a myeloid growth factor to maintain ANC greater than or equal to 1500/l, and therefore does not meet the criteria for a compensable rating.
- Whole decision: Remanded (sent back)
The Board remands the claims for service connection for meningitis and leukopenia due to a procedural due process violation.
- Whole decision: Remanded (sent back)
The Board remands the claims for service connection for leukopenia and prostatic hypertrophy due to additional development needed, including obtaining outstanding private treatment records and addendum opinions regarding the nature and etiology of the conditions.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.